| Fiscal Period | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Period End Date | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
| Total Operating Expense | 1,406.39 | 1,361.18 | 446.01 | 400.34 |
| Other Net | 15.02 | -12.37 | -5.91 | -8.50 |
| Diluted Weighted Average Shares | 11.46 | 11.04 | 11.44 | 11.44 |
| Depreciation/ Amortization | 279.09 | 273.88 | 76.29 | 65.68 |
| Total Extraordinary Items | 0.00 | -0.69 | -25.47 | -384.19 |
| Operating Income | 15.20 | 83.68 | -274.09 | -361.63 |
| Net Income | -73.80 | -17.97 | -391.17 | -799.83 |
| Income Availableto Com Excl Extra Ord | -73.80 | -17.28 | -365.70 | -415.65 |
| Other Operating Expenses Total | 430.47 | 0.66 | 0.40 | 0.76 |
| Net Income Before Taxes | -91.96 | -67.07 | -365.70 | -415.65 |
| Net Income After Taxes | -73.80 | -17.28 | -365.70 | -415.65 |
| Income Availableto Com Incl Extra Ord | -73.80 | -17.97 | -391.17 | -799.83 |
| Costof Revenue Total | 444.65 | 471.16 | 90.64 | 40.50 |
| Gross Profit | 976.94 | 973.70 | 81.28 | -1.78 |
| Interest Inc( Exp) Net- Non- Op Total | -122.18 | -138.15 | -79.89 | -45.51 |
| Unusual Expense( Income) | 9.93 | 110.74 | 115.94 | 145.14 |
| Diluted Net Income | -73.80 | -17.97 | -391.17 | -799.83 |
| Provisionfor Income Taxes | -18.16 | -49.79 | 0.00 | 0.00 |
| period Type | - | - | - | - |
| Net Income Before Extra Items | -73.80 | -17.28 | -365.70 | -415.65 |
| Total Revenue | 1,421.59 | 1,444.85 | 171.92 | 38.71 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Revenue | 1,421.59 | 1,444.85 | 171.92 | 38.71 |
| Selling/ General/ Admin Expenses Total | 242.25 | 502.69 | 162.73 | 148.27 |
| Diluted Normalized EPS | -5.88 | 4.97 | -21.32 | -23.64 |
| Diluted EPS Excluding Extra Ord Items | -6.44 | -1.57 | -31.96 | -36.32 |
| Gain( Loss)on Saleof Assets | - | -0.23 | -5.81 | 0.00 |
| Research Development | - | 2.05 | - | - |
| DPS- Common Stock Primary Issue | - | - | 0.00 | 0.00 |
Onesource Specialty Pharma Dividend Onesource Specialty Pharma Bonus Onesource Specialty Pharma News Onesource Specialty Pharma AGM Onesource Specialty Pharma Rights Onesource Specialty Pharma Splits Onesource Specialty Pharma Board Meetings Onesource Specialty Pharma Key Metrics Onesource Specialty Pharma Shareholdings Onesource Specialty Pharma Balance Sheet Onesource Specialty Pharma Cashflow Onesource Specialty Pharma Q1 Results Onesource Specialty Pharma Q2 Results Onesource Specialty Pharma Q3 Results Onesource Specialty Pharma Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.